Rigel Pharmaceuticals rigel.com


Public list: BIO 2016 (619) Smart Money VCs (6328) Pharma Startups (4732) Cancer Therapeutics (1137) Rare Diseases (230)

Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/ autoimmune diseases and cancer, as well as viral and metabolic diseases. Their research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Programs include rheumatoid arthritis, immune thrombocytopenia purpura and asthma.

Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/ autoimmune diseases and cancer, as well as viral and metabolic diseases. Their research focuses on intracellular signaling pathways and related targets that are cri...Show all

Company (IPO / Went public)

Phone: 650-624-1100

Fax:

1180 Veterans Boulevard

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rigel Pharmaceuticals $167.2M Jul 7, 2003
Amplimmune Immunology $20M Oct 7, 2013
Nurel Therapeutics $0M Nov 22, 2005
See all 59 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rigel Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 59 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pyrazole compounds and method for making and using the compounds Apr 22, 2016 May 29, 2018 Patent
Gdf-8 inhibitors Feb 15, 2016 May 29, 2018 Patent
In vivo reporter system Sep 26, 2011 May 15, 2018 Patent
Compositions and methods for inhibition of the jak pathway Feb 22, 2017 Mar 20, 2018 Patent
2,4-pyrimidinediamine compounds and their uses Jul 08, 2016 Mar 13, 2018 Patent
See all 256 patents